Navigation Links
ABI Testing Kit

ProductsABI Testing Kit
Company Nicolet Vascular
Item ABI Testing Kit
Features 
  • Nicolet Elite 100*, a reliable, highly-sensitive Doppler (a PocketDop II or StethoDop can be substituted with a price adjustment)
  • either a 5 MHz or 8 MHz probe
  • a selection of four quick disconnect vascular cuffs
  • sphygmomanometer
  • training CD
  • ABI chart
  • reference guide
  • report forms and vascular history questionnaire
  • 30-Day FREE Trial
  • Description To aid clinicians in performing Ankle/Brachial Index (ABI) testing, Nicolet Vascular has developed a new, complete packet of information. It includes a 10-minute compact disk ABI training presentation that can be viewed on any computer with a CD drive. It shows the step-by-step procedure of performing an ABI test, provides information on the materials that are needed, and indicates who is an appropriate candidate for the test. Also included in the packet is a quick-reference booklet of the CD presentation, a patient information brochure, and a report form and vascular history questionnaire with an ABI chart. Physicians find this information packet very useful for their own education, and the education of their staff and patients.
    Info Nicolet Vascular
    Customer Service: (800) 356-0007
    Web site: http://www.viasyshealthcare.com/

    Related medicine products :

    1. D-10 Hemoglobin Testing System with D-10™ Rack Loader
    2. Hgb Pro Professional Hemoglobin Testing System
    3. StressVue Exercise Stress Testing System
    4. Point Of Care Testing (POCT) Information System
    5. AAFP-PT Laboratory Proficiency Testing and Quality Assurance
    6. Clinical Proficiency Testing Programs
    7. VARIANT II TURBO Hemoglobin Testing System
    8. Sidekick™ Blood Glucose Testing System
    9. pH Testing - Advanced Analysis
    10. Anorectal Function Testing
    11. Standard pH Testing Application
    ... for the mid- to high-volume lab, the ... can reduce time-consuming manual tasks by as ... performs random access, STAT, HCFA panels and ... including Stat chemistries, General chemistries, TDMs, DATs, ...
    ... It takes powerful technology to ... safety, and still lower costs. ... LX20 PRO, offering features that ... any other chemistry analyzer, including ...
    ... This user-friendly instrument ... Plasma Protein analyzer for ... It is a well ... reliable results for a ...
    For Detection of Bile Component in Reflux Disease...
    Medicine Products:
    (Date:7/10/2014)... Texas (July 10, 2014) Men who experience hot ... they may find relief from their silent suffering ... according to findings from a Baylor University case study., ... man who had uncontrolled hot flashes following prostate cancer ... flashes but also an impressive improvement in sleep quality, ...
    (Date:7/9/2014)... -- The World Health Organization recommends that youth participate ... vigorous physical activity (MVPA) each day. Studies have ... school hours. Therefore, it stands to reason that ... In a new study scheduled for publication in ... time spent outdoors after school was positively associated with ...
    (Date:7/9/2014)... July 10, 2014 For the first time, researchers ... Aboriginal population in Canada uses health care. A new ... to clearly demonstrate the unique challenges faced by urban ... St. Michael,s Hospital. , The findings, published today ... urban First Nations individuals and the general population. , ...
    (Date:7/9/2014)... of Medicine at the University of Pennsylvania in collaboration ... $8 million grant from the National Cancer Institute (NCI) ... in patients with malignant pleural mesothelioma, a rare, aggressive ... the lining of the lungs and is caused almost ... a clinical trial and additional studies looking at the ...
    (Date:7/9/2014)... types of cancer sends the protein factories in our ... uncontrolled growth, new research suggests. , Scientists at The ... responsible for ratcheting up activity of the endoplasmic reticulum ... blocks cancer cells need to keep growing. , A ... the flow of messages to the endoplasmic reticulum telling ...
    Breaking Medicine News(10 mins):Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 2Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 3Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 4Health News:Go play outside! Outdoor time promotes physical activity in youth 2Health News:Urban Aboriginal people face unique health challenges 2Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Signal may send cancer's cellular factories into overdrive 2
    ... the current standard of care to treat opioid-dependent ... findings from an international team led by Johns Hopkins ... the New England Journal of Medicine . ... to counter heroin and/or prescription opioid addiction were likely ...
    ... Steven Reinberg HealthDay Reporter , THURSDAY, Dec. 9 ... on a new trick for weight loss: To eat less ... it up beforehand. Repeatedly imagining the consumption of a ... lead researcher Carey Morewedge, an assistant professor of social and ...
    ... of Cincinnati (UC) and Massachusetts General Hospital have ... may not be as beneficial to some patients ... findings were published online this week ahead of ... and Outcomes . Warfarin is commonly ...
    ... A genetic mutation associated with an inherited form of Lou ... lateral sclerosis (ALS) -- has been identified by an international ... are hereditary. In their study, the team used a ... the mutation in the valosin-containing protein (VCP) gene, which has ...
    ... (HealthDay News) -- Only 50 percent of women over age ... screen for breast cancer, even if they have insurance to ... a database of more than 12 million people to review ... the women included in the study had either employer-provided insurance ...
    ... of melanoma tumors by targeting the MIC-1 protein that ... better treatment of this invasive and deadly cancer, according ... Foreman Foundation Research Laboratory. , "Preventing vessels from developing ... growing," said lead author Gavin Robertson, Ph.D., professor of ...
    Cached Medicine News:Health News:Buprenorphine is better than methadone for opioid dependence in pregnant women, study shows 2Health News:Mental Imagery a New Weight-Loss Tool? 2Health News:Mental Imagery a New Weight-Loss Tool? 3Health News:Blood-thinning treatment standards changing for heart patients, new research shows 2Health News:Blood-thinning treatment standards changing for heart patients, new research shows 3Health News:Only Half of Women Over 40 Get Annual Mammograms 2Health News:Protein targeted to stop melanoma tumor growth 2
    (Date:1/15/2014)... to Millennium Research Group (MRG), the global authority ... United States and European transcatheter embolization ... through 2022, with embolization particles representing one of ... drug-eluting beads (DEBs) and radioembolization spheres in interventional ...
    (Date:1/15/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") ... its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), for ... Solta Medical, Inc. (NASDAQ: SLTM ) ("Solta") ...
    (Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a leading ... of severely obese patients, today announced initial results ... selective inhibitor of methionine aminopeptidase 2 (MetAP2), in ... of genetic obesity.  These results showed improvements in ...
    Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4